Understanding Pregabalin Impurities: The Role of (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic Acid Standards
Ensuring the safety and efficacy of pharmaceutical products requires rigorous control over impurities. For widely used medications like Pregabalin, understanding and managing potential impurities is a critical aspect of quality control and regulatory compliance. (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid, a key intermediate in Pregabalin synthesis, plays a dual role: it is essential for producing the drug, and it also serves as a vital reference standard for identifying and quantifying specific Pregabalin impurities. NINGBO INNO PHARMCHEM CO.,LTD. supplies this compound to support these crucial impurity profiling efforts.
Pregabalin, prescribed for neuropathic pain, epilepsy, and anxiety disorders, has a well-defined synthesis pathway that involves several chemical transformations. During these processes, various by-products and related substances can emerge, which are classified as impurities. (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid (CAS No. 181289-33-8) itself can be present as an unreacted starting material or as a precursor to certain process-related impurities. Therefore, having access to a high-purity sample of this intermediate is essential for establishing accurate Pregabalin impurity standards.
NINGBO INNO PHARMCHEM CO.,LTD. provides (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid that meets the exacting purity requirements needed for reference standards. Pharmaceutical manufacturers use these standards in analytical methods, such as HPLC, to detect and quantify even trace amounts of impurities in their Pregabalin batches. By comparing the analytical signals from their drug product to those of the reference standard, companies can confirm that their manufacturing process is under control and that the final API is compliant with pharmacopoeial limits and regulatory guidelines.
The chemical synthesis of anticonvulsant drugs is a highly regulated field, and maintaining a low impurity profile is a key objective. The availability of reliable intermediates, which can also function as impurity reference materials, significantly aids in achieving this goal. NINGBO INNO PHARMCHEM CO.,LTD. understands the importance of providing materials that support comprehensive analytical testing. Our consistent supply of high-quality (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid empowers our clients to conduct thorough impurity analysis, thereby enhancing the overall safety and quality of their Pregabalin products.
In essence, (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid is a multifaceted component in the pharmaceutical manufacturing process. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying this compound, not only as a critical synthesis intermediate but also as an indispensable tool for ensuring the purity and safety of Pregabalin through robust impurity profiling.
Perspectives & Insights
Molecule Vision 7
“provides (R)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid that meets the exacting purity requirements needed for reference standards.”
Alpha Origin 24
“Pharmaceutical manufacturers use these standards in analytical methods, such as HPLC, to detect and quantify even trace amounts of impurities in their Pregabalin batches.”
Future Analyst X
“By comparing the analytical signals from their drug product to those of the reference standard, companies can confirm that their manufacturing process is under control and that the final API is compliant with pharmacopoeial limits and regulatory guidelines.”